Related Experiment Video
Updated: Apr 13, 2026

07:47
Surgical Ablation Assay for Studying Eye Regeneration in Planarians
Published on: April 14, 2017
11.6K
Single-cell transcriptomics and RNAi screening define a hierarchical program of planarian eye regeneration
M Lucila Scimone1, Bryanna I Canales2, Patrick Aoude3
1Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Cell Reports
|April 11, 2026
Summary
Planarians regenerate eyes through a hierarchical genetic program. This study defines key steps from progenitor cells to mature eye structures, offering insights into organ regeneration and eye development.
Area of Science:
- Developmental Biology
- Regenerative Medicine
- Genetics
Background:
- Eye evolution and disease are complex biological challenges.
- Planarians offer a unique model for studying eye regeneration due to their remarkable ability to regrow eyes after injury.
Purpose of the Study:
- To define the hierarchical sequence of cellular and genetic events during planarian eye regeneration.
- To identify key genes controlling each stage of eye development and regeneration.
Main Methods:
- Single-cell transcriptomic analysis of regenerating eyes.
- Large-scale RNA interference (RNAi) screening to assess gene function.
Main Results:
- A step-by-step genetic program for eye regeneration was elucidated, from progenitor cell specification to photoreceptor and optic cup cell differentiation.
- Key processes including rhabdomere formation, dorsal projection development, and eye morphogenesis were characterized.
- The role of conserved genes and extracellular environment interactions in forming a transparent optical region was highlighted.
Conclusions:
- The study establishes a comprehensive framework for understanding organ regeneration, specifically focusing on the conserved genetic mechanisms underlying eye development.
- This research provides foundational knowledge for investigating human eye diseases and advancing regenerative therapies.

